Serum Irisin Predicts Posthepatectomy Complications in Patients with Hepatocellular Carcinoma.

Conclusions: Irisin may be a novel serum biomarker in the diagnosis of HCC and a predictor of complications after hepatectomy.
PMID: 31976024 [PubMed - in process]

Source: Disease Markers - January 25, 2020 Category: Laboratory Medicine Tags: Dis Markers Source Type: research